Head of Investor Relations
Mark Namaroff
Head of Investor Relations
Anika Therapeutics, Inc. (ANIK)Head of Investor Relations
Azenta, Inc. (AZTA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark Namaroff
Mark Namaroff is recorded as Head of Investor Relations at Anika Therapeutics, Inc. (ANIK) and Head of Investor Relations at Azenta, Inc. (AZTA). Mark Namaroff has spoken on 15 earnings calls across 2 companies, most recently for Anika Therapeutics, Inc. on August 8, 2024.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
AZTA
Head of Investor Relations
Leadership on record at Anika Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Cheryl Blanchard CEO, Board Member
- Stephen (Steve) Griffin CEO, Board Member
- Stephen D. Griffin CEO, CFO, Board Member
- Steve Griffin CEO, Board Member
- Cheryl R. Blanchard Chairman, Board Member
- Jeffery S. Thompson Chairman
- John B. Henneman, III Chairman, Board Member
- Michael Levitz CFO
- Stephen Griffin CFO
- Anne Nunes COO
Leadership on record at Azenta, Inc.
Other people whose current roles at this company are on record from its filings.
- John Marotta CEO, Board Member
- John P. Marotta CEO
- Martin D. Madaus CEO
- Lawrence Lin CFO
- Lawrence Y. Lin CFO
- Ephraim Starr General Counsel
- Erik J. Bello Chief Accounting Officer
- Vandana Sriram Chief Accounting Officer
- Alan J. Malus Board Member
- Alan Malus Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.